MassRobotics Healthcare Catalyst Cohort 6 Opens With Intel on the Steering Committee

If you build robotics or automation for clinical settings, the Healthcare Robotics Startup Catalyst Program is worth a close look. Cohort 6 is open, and the program is built around milestones an engineering team can actually hit in four months: a proof-of-concept build, a pilot design, a regulatory plan, or a systems integration step. It's non-equity, which means the mentoring comes without a stake in the company.

What the program is designed to move

The Catalyst Program targets robotics and automation teams that need to accelerate three things at once: clinical readiness, technical validation, and go-to-market in healthcare and life sciences. Those three goals pull in different directions. A team validating a precision motion stage for a lab workflow has different problems from a team preparing a surgical robot for a first clinical study, and the program is meant to handle both kinds of problem inside one cohort.

Teams in this position often struggle less with the engineering itself than with sequencing. Which test protocol comes first? When does a pilot design need to be locked? How early should cybersecurity work begin on a connected device? A structured four-month track with biweekly mentor sessions is a practical way to force those decisions into the open early, before they turn into schedule slips.

The cohort runs February through June 2027 and ends with company showcases at the Robotics Summit and Expo in Boston. For teams that want a public stage to present results, that June showcase is a concrete deadline to plan toward.

Intel joins the steering committee

This year, MassRobotics added Intel to the program's steering committee, alongside founding members Festo, Novanta, and Mitsubishi Electric US. Intel's Health and Life Sciences team is bringing mentorship and technical depth in edge AI and on-device compute. The source frames that focus around surgical and procedure-enabling robotics and operating room automation, which it describes as an area of growing interest across the cohort.

That's a meaningful addition for teams whose designs depend on processing close to the sensor or the actuator. When a robot has to make decisions in the room, latency, power budget, and how inference hardware fits into a validated medical device all become engineering constraints rather than software details. Having mentors who work on those trade-offs directly gives applicants a sharper sounding board than generic startup advice.

Who the mentors are

Selected startups are matched with senior mentors from Festo, Novanta, Mitsubishi Electric US, Intel, and yaxxoo. The program also draws on practicing clinicians and leading organizations in the medical field, and it includes a Medical Advisory Board that provides clinical perspective.

Mentor support runs through structured onboarding, goal setting, and biweekly working sessions. The custom workshops are set by what the cohort needs, and the source lists regulatory strategy, cybersecurity and SBOMs, clinical workflow, and pilot design among the likely topics. An SBOM, or software bill of materials, is becoming a routine request when a connected medical device goes through review, so a workshop on it is more practical than it might sound at first.

Track record since 2021

Since 2021, the Catalyst Program has mentored 35 startups spanning pre-seed through Series A. The source notes that these teams are headquartered in places as varied as Boston, Toronto, Paris, Barcelona, and Sydney. That geographic spread matters for a field where clinical access, reimbursement, and manufacturing relationships often differ from one country to the next.

Alumni results cited in the announcement include one company completing a public listing, several advancing multiple proof-of-concept deployments, and a combined total of more than $180 million in disclosed funding raised. Those are the program's own figures, reported by MassRobotics, and they describe outcomes across alumni companies rather than a controlled comparison. Still, they point to the kind of progress the program is trying to support: moving from early prototype to a platform that someone in a hospital or lab will sign off on.

What founders and sponsors are saying

Johannes Linzbach, Head of Research Hub Boston at Festo, has supported the program for three years. In his words: "Having supported the MassRobotics Healthcare Catalyst Program for three years, I'm proud of the journey we at Festo have taken — from founding member to seeing standout startups like Tenomix thrive. What I love most is discovering the people behind the technology: their ambition, their ideas, and what drives them. At Festo, we're excited to support Cohort 6 with our experience and connections across the ecosystem as they turn those ideas into solutions that can scale."

Bingda Li, CEO of Whelix, describes the value from the founder's side: "The MassRobotics Healthcare Catalyst Program gave us exactly what a deep-tech startup needs: direct access to people who have experienced similar problems before. The technical support from Festo and Mitsubishi Electric US, combined with mentorship across technical development, business strategy, go-to-market, and product feedback, helped us make sharper decisions faster. We are grateful to the MassRobotics team and the mentors who invested their time in Whelix, and we encourage other robotics startups in healthcare and life science to apply."

Founder testimony like Li's tends to land hardest with teams that have stalled between a working lab prototype and a credible pilot. Her emphasis on faster, sharper decisions speaks to the sequencing problem again: the value is often in who a team talks to in month two, not in a single piece of advice.

Who should apply and how selection works

Eligible companies build robotics or automation for healthcare and biotech. The source lists a wide range of areas, including lab and pharma automation, diagnostics and imaging workflows, hospital logistics and OR automation, rehabilitation and assistive devices, and surgical and interventional robotics. It also counts enabling technologies such as sensing, precision motion, edge AI and on-device compute, and cybersecurity for medical devices. The program is open to robotics startups anywhere in the world, and companies from Seed through Series C are encouraged to apply.

Applicants are judged on technical maturity, clinical relevance, feasibility of near-term milestones, program fit, and mentor alignment. The announcement singles out teams that can pursue a proof-of-concept during the four months. If your roadmap has a bench-level demonstration within reach of a single cohort, that's the kind of fit the selection process appears to reward.

Dates and how to apply

The key dates are as follows. Applications close December 31, 2026. Evaluation and interviews run January 1 to January 20, 2027. The cohort announcement is scheduled for January 29, 2027, and the program period runs February to June 2027.

To apply, complete the application here. Questions can go to [email protected]. The full program details are on the MassRobotics Healthcare Robotics Startup Catalyst Program page.

My read: the strongest applications will be the ones that already have a specific clinical question and a near-term build in mind. The program rewards teams that can point to a proof-of-concept they can finish by June, and with Intel now at the table on edge compute, teams with on-device processing problems have a new reason to look closely. Cohort 6 closes at the end of the year, so the window for a considered application is shorter than it looks.